Literature DB >> 20679895

Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.

Gaetano Giorgio D'Ambrosio1, Salvatore Campo, Maurizio Cancian, Serena Pecchioli, Giampiero Mazzaglia.   

Abstract

The practice of prostate-specific antigen (PSA) screening has been increasing in Italy despite uncertain scientific evidence and contrary recommendations from most scientific societies. In 2002, a survey of PSA screening diffusion among general practices was performed, looking for screening frequency and age pattern of screened individuals. The objective of this study was to assess whether the features of PSA screening did change after 6 years in the same considered setting. Using the data obtained from 500 Italian general practitioners providing information to the Health Search/CSD Patient database, we selected, for the study purpose 351,091 male individuals. We assumed PSA prescriptions performed during 2005-2008 in individuals without prostate cancer, or benign prostate disease, or urological symptoms history to have a screening purpose. Screening frequency was analyzed in the overall series, by year and by patient's age. Exposure to PSA screening (at least on PSA test in the considered period) of males aged over 50 years raised from 31.4% (confidence interval 95% 31.08-31.70%) during 2002 to 46.4% (confidence interval 95% 46.19-46.68%) during 2008. The highest yearly exposure to PSA screening (55%) and the highest frequency of repeat testing was observed in the 70-79 age range. PSA screening practice has continued to increase in Italy and is often performed in elderly people without any scientific rationale.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679895     DOI: 10.1097/CEJ.0b013e32833d944b

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  8 in total

1.  Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.

Authors:  Vincenzo Mirone; Ciro Imbimbo; Davide Arcaniolo; Marco Franco; Roberto La Rocca; Luca Venturino; Lorenzo Spirito; Massimiliano Creta; Paolo Verze
Journal:  World J Urol       Date:  2017-08-05       Impact factor: 4.226

2.  Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men.

Authors:  Stephen J Lepore; Rasmi G Nair; Stacy N Davis; Randi L Wolf; Charles E Basch; Nigel Thomas; Celia Shmukler; Ralph Ullman
Journal:  J Immigr Minor Health       Date:  2017-12

3.  [Rates of prostate-specific antigen testing for early detection of prostate cancer: a first comparison of German results with current international data].

Authors:  S Lebentrau; M May; O Maurer; M Schostak; M Lehsnau; T Ecke; S Al-Dumaini; S Hallmann; A M Ahmed; V Braun; A Haferkamp; R M Bauer; C G Stief; D Baumunk; B Hoschke; H-P Braun; C Schäfer; M Hipp; J Maurer; K-P Braun; I Wolff; S Brookman-May; C Gilfrich
Journal:  Urologe A       Date:  2014-05       Impact factor: 0.639

4.  Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer.

Authors:  Paola Mosconi; Cinzia Colombo; Roberto Satolli; Sara Carzaniga
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 5.  Prevalence of incidental prostate cancer: A systematic review of autopsy studies.

Authors:  Katy J L Bell; Chris Del Mar; Gordon Wright; James Dickinson; Paul Glasziou
Journal:  Int J Cancer       Date:  2015-04-21       Impact factor: 7.396

6.  Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?

Authors:  Paul Nderitu; Mieke Van Hemelrijck; Mark Ashworth; Rohini Mathur; Sally Hull; Alexandra Dudek; Simon Chowdhury
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

7.  Drift compensation on electronic nose data for non-invasive diagnosis of prostate cancer by urine analysis.

Authors:  Carmen Bax; Stefano Prudenza; Giulia Gaspari; Laura Capelli; Fabio Grizzi; Gianluigi Taverna
Journal:  iScience       Date:  2021-12-16

8.  Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran.

Authors:  Amir-Reza Abedi; Morteza Fallah-Karkan; Farzad Allameh; Arash Ranjbar; Afshin Shadmehr
Journal:  Res Rep Urol       Date:  2018-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.